Clinical Trials Browser

Phase 2 × Lymphoma, T-Cell × Magnetic Resonance Spectroscopy × Clear all

NCT07293403 2025-12-19

Duvelisib Maintenance for the Treatment of Peripheral T-Cell Lymphomas

Phase 2 Not yet recruiting

Lymphoma, T-Cell